Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months
NCT01436136
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infection
Cardiovascular Disease
Interventions
OTHER:
Control
OTHER:
Intervention Group
Sponsor
Holdsworth House Medical Practice